Nationality Dutch Field Medicine | Fields clinical medicine Thesis 1989 | |
 | ||
Alma mater University of Amsterdam B.Sc in Biology and M.Sc in Molecular Oncology, University of Leiden Ph.D. Notable awards IARC Medal of Honor (2005), ESMO Lifetime Achievement Award for Translational Research in Breast Cancer (2007), Breast Cancer Research Fund (BCRF-Pink Ribbon US) grant award (2007) (2008), European Inventor Award (2015) Institutions University of California, San Francisco, Netherlands Cancer Institute | ||
Laura Johanna van 't Veer (born 1957) is a Molecular Biologist, Clinical Molecular Geneticist, and Group Leader Molecular Pathology for the Department of Pathology and Division of Experimental Therapy of The Netherlands Cancer Institute
Contents
Education
Attended the University of Amsterdam from 1976–1984 and received a B.Sc in Biology and M.Sc in Molecular Oncology. She continued her studies at the University of Leiden from 1984–1989. She would earn her PhD focusing on the study of Oncogene Activation and Tumorigenesis.
Career
In 2003 Dr. van ‘t Veer cofounded Agendia B.V. in 2003, serving as the Chief Operating Officer of Agendia B.V. until June 12, 2007. She continues her work with the company today as Chief Research Officer. She was featured in the cover story of the MAY-JUNE 2006 issue of Cancer World. With her colleagues in the field, she has been awarded a number of patents related to cancer treatment. Has been a member of the Science Policy and Government Affairs Committee of the American Association for Cancer Research since 2014. From 2013–2014 she was a member of the Education and Training Committee. She has more than 80 peer reviewed publications to her name.